查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1418354

吗啡市场报告：2030 年趋势、预测与竞争分析

Morphine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

吗啡趋势和预测

预计2024年至2030年全球吗啡市场将以8.1%的复合年增长率成长。市场的主要驱动力是癌症和其他疾病患者数量的迅速增加以及吗啡在疼痛治疗中的使用不断增加。全球吗啡市场的未来似乎在医院/诊所市场和门诊手术中心市场有机会。

吗啡市场洞察

Lucintel 预测，由于神经系统疾病的增加，注射剂在预测期内仍将是最大的细分市场。

由于处方数量较多，医院和诊所仍然是该市场中最大的部分。

由于慢性病的迅速增加，北美在预测期内将继续成为最大的地区。

常问问题

Q1.市场成长预测如何？

A1. 2024年至2030年，全球吗啡市场预计将以8.1%的复合年增长率成长。

Q2.影响市场成长的主要驱动因素有哪些？

A2. 该市场的主要驱动力是癌症和其他疾病的迅速增加以及吗啡在疼痛治疗中的使用不断增加。

Q3.市场的主要细分市场有哪些？

A3. 吗啡市场前景广阔，医院和诊所市场以及门诊手术中心市场充满机会。

Q4.市场上主要企业有哪些？

A4. 主要的吗啡公司如下。

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health Care

Q5.未来最大的细分市场是什么？

A5.Lucintel 预计，由于神经系统疾病的增加，注射剂在预测期内仍将是其最大的细分市场。

Q6. 未来五年预计哪个地区将成为最大的市场？

A6. 由于慢性病的快速增加，北美在预测期内将继续成为最大的地区。

Q7. 可以客製化报告吗？

A7. 是的，Lucintel 提供 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球吗啡市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球吗啡市场趋势（2018-2023）与预测（2024-2030）
  • 按剂型分類的全球吗啡市场
    • 注射
    • 口服锭剂
    • 其他的
  • 按分销管道分類的全球吗啡市场
    • 医院药房
    • 零售药房
    • 网路药房
    • 其他的
  • 全球吗啡市场的应用
    • 疼痛管理
    • 腹泻抑制剂
    • 感冒和止咳药
    • 其他的
  • 按最终用途分類的全球吗啡市场
    • 医院和诊所
    • 门诊手术中心
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球吗啡市场区域分布
  • 北美吗啡市场
  • 欧洲吗啡市场
  • 亚太吗啡市场
  • 其他地区吗啡市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按剂型分類的全球吗啡市场成长机会
    • 按分销管道分類的全球吗啡市场成长机会
    • 全球吗啡市场成长机会（按应用）
    • 全球吗啡市场成长机会（依最终用途）
    • 全球吗啡市场成长机会（按地区）
  • 全球吗啡市场新趋势
  • 战略分析
    • 新产品开发
    • 全球吗啡市场产能扩张
    • 全球吗啡市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health care
简介目录

Morphine Trends and Forecast

The future of the global morphine market looks promising with opportunities in the hospitals & clinics and ambulatory surgical centers markets. The global morphine market is expected to grow with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are surge in cancer and other disease cases accentuates and escalating utilization of morphine for pain management.

A more than 150-page report is developed to help in your business decisions.

Morphine by Segment

The study includes a forecast for the global morphine by dosage form, distrbution channel, application, end use, and region.

Morphine Market by Dosage Form [Shipment Analysis by Value from 2018 to 2030]:

  • Injection
  • Oral Tablets
  • Others

Morphine Market by Distrbution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Morphine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pain Management
  • Diarrhea Suppressant
  • Cold And Cough Suppressant
  • Others

Morphine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Morphine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Morphine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies morphine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the morphine companies profiled in this report include-

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health Care

Morphine Market Insights

Lucintel forecasts that injection will remain the largest segment over the forecast period due to growing occurrence of neurological diseases.

Within this market, hospitals and clinics will remain the largest segment due to high prescriptions.

North America will remain the largest region over the forecast period due to surging prevalence of chronic diseases.

Features of the Global Morphine Market

Market Size Estimates: Morphine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Morphine market size by various segments, such as by dosage form, distrbution channel, application, end use, and region in terms of value ($B).

Regional Analysis: Morphine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different dosage form, distrbution channel, application, end use, and regions for the morphine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the morphine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for morphine market?

Answer: The global morphine market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the morphine market?

Answer: The major drivers for this market are surge in cancer and other disease cases accentuates and escalating utilization of morphine for pain management.

Q3. What are the major segments for morphine market?

Answer: The future of the morphine market looks promising with opportunities in the hospitals & clinics and ambulatory surgical centers markets.

Q4. Who are the key morphine market companies?

Answer: Some of the key morphine companies are as follows.

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health Care

Q5. Which morphine market segment will be the largest in future?

Answer: Lucintel forecasts that injection will remain the largest segment over the forecast period due to growing occurrence of neurological diseases.

Q6. In morphine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surging prevalence of chronic diseases.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the morphine market by dosage form (injection, oral tablets, and others), distrbution channel (hospital pharmacies, retail pharmacies, online pharmacies, and others), application (pain management, diarrhea suppressant, cold and cough suppressant, and others), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Morphine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Morphine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Morphine Market by Dosage Form
    • 3.3.1: Injection
    • 3.3.2: Oral Tablets
    • 3.3.3: Others
  • 3.4: Global Morphine Market by Distrbution Channel
    • 3.4.1: Hospital Pharmacies
    • 3.4.2: Retail Pharmacies
    • 3.4.3: Online Pharmacies
    • 3.4.4: Others
  • 3.5: Global Morphine Market by Application
    • 3.5.1: Pain Management
    • 3.5.2: Diarrhea Suppressant
    • 3.5.3: Cold and Cough Suppressant
    • 3.5.4: Others
  • 3.6: Global Morphine Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Morphine Market by Region
  • 4.2: North American Morphine Market
    • 4.2.3: North American Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.3: European Morphine Market
    • 4.3.1: European Morphine Market by Dosage Form: Injection, Oral Tablets, and Others
    • 4.3.3: European Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Morphine Market
    • 4.4.1: APAC Morphine Market by Dosage Form: Injection, Oral Tablets, and Others
    • 4.4.3: APAC Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Morphine Market
    • 4.5.1: ROW Morphine Market by Dosage Form: Injection, Oral Tablets, and Others
    • 4.5.3: ROW Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Morphine Market by Dosage Form
    • 6.1.2: Growth Opportunities for the Global Morphine Market by Distrbution Channel
    • 6.1.3: Growth Opportunities for the Global Morphine Market by Application
    • 6.1.4: Growth Opportunities for the Global Morphine Market by End Use
    • 6.1.5: Growth Opportunities for the Global Morphine Market by Region
  • 6.2: Emerging Trends in the Global Morphine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Morphine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Morphine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Mallinckrodt Pharmaceuticals
  • 7.2: Alcaliber
  • 7.3: Purdue Pharma
  • 7.4: Sanofi Winthrop Industries
  • 7.5: Macfarlan Smith
  • 7.6: Sun Pharmaceutical Industries
  • 7.7: Qinghai Pharmaceutical
  • 7.8: Northeast Pharmaceutical
  • 7.9: Pfizer
  • 7.10: Verve Health care